Both in humans with Alzheimer's disease (AD) and murine models of AD and frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS), MYO1F is significantly upregulated in microglia compared to healthy controls. This evidence concerns the gene MYO1F and frontotemporal dementia.